The basophil histamine release test in the diagnosis of atopic bronchial asthma in children

1999 ◽  
Vol 48 (13) ◽  
pp. 45-46 ◽  
Author(s):  
E. Botuliñska ◽  
J. Tobolczyk ◽  
A. Stasiak-Barmuta ◽  
J. Hofman
Keyword(s):  
Histamine Release ◽  
Bronchial Asthma ◽  
Atopic Bronchial Asthma ◽  
Release Test ◽  
Asthma In Children

Peculiarities of the clinical course bronchial asthma in children

1998 ◽  
Vol 79 (5) ◽  
pp. 346-348
Author(s):  
V. N. Tsybulkina ◽  
G. M. Zainetdinova ◽  
G. A. Shamsutdinova ◽  
A. N. Salikhova
Keyword(s):  
Effective Treatment ◽  
Bronchial Asthma ◽  
Specific Immunotherapy ◽  
Clinical Course ◽  
Treatment Method ◽  
Young Age ◽  
Age Group ◽  
Atopic Bronchial Asthma ◽  
Increased Sensitivity ◽  
Asthma In Children

It is established that in most of patients the course of atopic bronchial asthma occurs as clinical attacks of expiratory asphyxia repeated both by day and at night. In children aged 1 to 6 the course of this disease is principally slight, medium and grave. In elder age group (715 years) the share ef graver forms of bronchial asthma increases. The disease is determined by increased sensitivity to domestic allergens. Atypical forms are found only in young age group and obviously are not connected with hypersensitivity. The specific immunotherapy is an effective treatment method of the classical atopic bronchial asthma in children aged 7 to 15.

scholarly journals IMMUNOLOGICAL MARKERS OF UNCONTROLLED ATOPIC BRONCHIAL ASTHMA IN CHILDREN

2017 ◽  
Vol 19 (4) ◽  
pp. 453-460 ◽  
Author(s):  
M. V. Smolnikova ◽  
S. V. Smirnova ◽  
N. A. Ilyenkova ◽  
O. S. Konopleva
Keyword(s):  
Bronchial Asthma ◽  
Atopic Bronchial Asthma ◽  
Immunological Markers ◽  
Asthma In Children

scholarly journals Experience in Course of Anti-IgE Therapy of Bronchial Asthma in Children

2021 ◽  
Vol 65 (6) ◽  
pp. 116-121
Author(s):  
S. E. Dyakova ◽  
Yu. L. Mizernitskiy ◽  
L. V. Sokolova ◽  
I. E. Zorina ◽  
A. E. Bogorad
Keyword(s):  
Bronchial Asthma ◽  
Respiratory Infections ◽  
Specific Ige ◽  
Patient Specific ◽  
Disease Exacerbation ◽  
Specific Therapy ◽  
Exacerbation Rate ◽  
Atopic Bronchial Asthma ◽  
Ige Receptors ◽  
Asthma In Children

The results of the clinical approbation of Patient-specific therapy of bronchial asthma in children using the course method of application of the monoclonal antibodies (anti-IgE-therapy) by the Ministry of Health are summarized in order to assess the effect of this type of treatment on the disease exacerbation rate, including those associated with the seasonal acute respiratory infections. The conclusion was made regarding the high clinical efficiency in relation to all parameters studied and safety of this type of the treatment. It was determined that the monitoring of the level of specific IgE receptors on basophils using the cytoflowmetry method, which is concomitant to anti-IgE therapy, makes it possible to predict the efficiency and individual duration of anti-IgE therapy for uncontrolled atopic bronchial asthma in children.

INFLUENCE OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY ON THE DYNAMICS OF SENSITIZATION INDICATORS IN ATOPIC BRONCHIAL ASTHMA IN CHILDREN

2021 ◽  
Vol Special issue (1) ◽  
pp. 22-25
Author(s):  
Azod Akhmedovich Nazarov ◽  
◽  
Farida Rustamovna Mirzakarimova ◽  
Keyword(s):  
Bronchial Asthma ◽  
Specific Immunotherapy ◽  
Systemic Approach ◽  
Atopic Asthma ◽  
Preventive Effect ◽  
Allergen Specific Immunotherapy ◽  
Atopic Bronchial Asthma ◽  
Asthma In Children

Of all the currently existing methods of treating atopic asthma, the most vivid example of a systemic approach is sublingual allergen-specific immunotherapy (SL ASIT). Allergen-specific immunotherapy (ASIT) is the only method of antiallergic treatment that affects all pathogenetic links of the allergic process and has a long-term preventive effect (Gushchin I.S., 1998).Keywords:atopic bronchial asthma, sensitization, epidemiology, specific immunotherapy

Sign in / Sign up

Export Citation Format

Share Document